For more than 25 years, lab-on-a-chip technology has allowed researchers to model human organs and blood vessels using real ...
Hosted on MSN
Chart master: Is it time to buy biotech?
Carter Worth, Worth Charting, joins 'Fast Money' to talk the technicals on biotech. Coffee linked to significant new side effect, says massive study Saudi Arabia opens new front in Iran war The Trump ...
Carter Worth, Worth Charting, joins 'Fast Money' to talk the technicals on biotech. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to ...
Daniel covers the intersection of the health industry and the federal government. He reports on corporate influence in government, the health consequences of federal policies, and the politics of ...
I have this idea of a communal brain.” David Baker, PhD, told me as I sat in his office at the University of Washington (UW) ...
Vancouver biotechnology company Zymeworks Inc. (Nasdaq:ZYME) plans to spend US$929 million in cash to buy Theravance Biopharma Inc. (Nasdaq:TBPH), the companies announced Monday, June 29. Share prices ...
Drivers are facing long delays on a notoriously congested A-road after temporary traffic lights were installed to allow for drainage works. Engineers from Kent County Council (KCC) have installed ...
The Proline Promass U 500 Coriolis flowmeter is the first single-use flowmeter for biotech applications, offering superior performance, cGMP compliance, and up to four I/Os. The Promass U 500 is the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results